134 related articles for article (PubMed ID: 1727343)
1. MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits.
Hamm B; Taupitz M; Hussmann P; Wagner S; Wolf KJ
AJR Am J Roentgenol; 1992 Jan; 158(1):183-90. PubMed ID: 1727343
[TBL] [Abstract][Full Text] [Related]
2. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance lymphography in rats: effects of muscular activity and hyperthermia on the lymph node uptake of intravenously injected superparamagnetic iron oxide particles.
Elste V; Wagner S; Taupitz M; Pfefferer D; Kresse M; Hamm B; Berg R; Wolf KJ; Semmler W
Acad Radiol; 1996 Aug; 3(8):660-6. PubMed ID: 8796730
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles in detecting lymph node metastasis of tumors: an experimental study].
Wu YK; Xu YK; Zhang JN; Wu FL; Liu XY; Huang QL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):62-4. PubMed ID: 12527520
[TBL] [Abstract][Full Text] [Related]
5. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
[TBL] [Abstract][Full Text] [Related]
6. MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumor model.
Taupitz M; Wagner S; Hamm B; Dienemann D; Lawaczeck R; Wolf KJ
Acta Radiol; 1993 Jan; 34(1):10-5. PubMed ID: 8427741
[TBL] [Abstract][Full Text] [Related]
7. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
8. Experimental lymph node metastases: enhanced detection with MR lymphography.
Weissleder R; Elizondo G; Josephson L; Compton CC; Fretz CJ; Stark DD; Ferrucci JT
Radiology; 1989 Jun; 171(3):835-9. PubMed ID: 2717761
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide-enhanced MR imaging: pulse sequence optimization for detection of liver cancer.
Fretz CJ; Elizondo G; Weissleder R; Hahn PF; Stark DD; Ferrucci JT
Radiology; 1989 Aug; 172(2):393-7. PubMed ID: 2748820
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Invest Radiol; 2012 Sep; 47(9):511-5. PubMed ID: 22864375
[TBL] [Abstract][Full Text] [Related]
11. Optimization of pulse sequences in magnetic resonance lymphography of axillary lymph nodes using magnetic nanoparticles.
Gharehaghaji N; Oghabian MA; Sarkar S; Amirmohseni S; Ghanaati H
J Nanosci Nanotechnol; 2009 Jul; 9(7):4448-52. PubMed ID: 19916472
[TBL] [Abstract][Full Text] [Related]
12. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
Liu X; Xu YK; Huang QL; Wu YK
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
[TBL] [Abstract][Full Text] [Related]
13. [High-resolution T1-weighted MR-lymphography of inguinal lymph nodes after interstitial application of Gadomer-17 in animal experiments].
Staatz G; Spüntrup E; Klosterhalfen B; Misselwitz B; Pflüger D; Günther RW; Bücker A
Rofo; 2005 Jul; 177(7):968-74. PubMed ID: 15973599
[TBL] [Abstract][Full Text] [Related]
14. [Interstitial T1-weighted MR lymphography with use of the dendritic contrast agent Gadomer-17 in pigs].
Staatz G; Nolte-Ernsting CC; Bücker A; Misselwitz B; Grosskortenhaus S; Pflüger D; Günther RW
Rofo; 2001 Dec; 173(12):1131-6. PubMed ID: 11740675
[TBL] [Abstract][Full Text] [Related]
15. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.
Anzai Y; McLachlan S; Morris M; Saxton R; Lufkin RB
AJNR Am J Neuroradiol; 1994 Jan; 15(1):87-94. PubMed ID: 7511324
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals.
Frank H; Weissleder R; Brady TJ
AJR Am J Roentgenol; 1994 Jan; 162(1):209-13. PubMed ID: 8273667
[TBL] [Abstract][Full Text] [Related]
17. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
Weissleder R; Elizondo G; Wittenberg J; Lee AS; Josephson L; Brady TJ
Radiology; 1990 May; 175(2):494-8. PubMed ID: 2326475
[TBL] [Abstract][Full Text] [Related]
18. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
Bartolotta TV; Midiri M; Galia M; Carcione A; De Maria M; Lagalla R
Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
[TBL] [Abstract][Full Text] [Related]
19. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T.
Marchal G; Van Hecke P; Demaerel P; Decrop E; Kennis C; Baert AL; van der Schueren E
AJR Am J Roentgenol; 1989 Apr; 152(4):771-5. PubMed ID: 2784260
[TBL] [Abstract][Full Text] [Related]
20. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
Guimaraes R; Clément O; Bittoun J; Carnot F; Frija G
AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
